Weier Bao
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
Papers in
-
- Nanoplatforms for cancer theranostics 22
-
- Advanced Nanomaterials in Catalysis 8
- Luminescence and Fluorescent Materials 5
- Co-authors
- Wei Wei (20 shared papers)Feng Li (10 shared papers)Guihong Lu (8 shared papers)Yanlin Lv (6 shared papers)Shuang Wang (7 shared papers)Zhiyuan Tian (16 shared papers)Fan Zhang (3 shared papers)Bin Liu (5 shared papers)
- Journals
- Small (5 papers)ACS Nano (3 papers)Advanced Materials (3 papers)Nature Communications (2 papers)Sensors and Actuators B Chemical (2 papers)
- Partner nations
- ChinaNetherlandsSaudi Arabia
In The Last Decade
Weier Bao
34 papers receiving 2.1k citations
Weier Bao's Hit Papers
Peers
Comparison fields: 5 of 99
- Biomaterials 427
- Biomedical Engineering 1.1k
- Materials Chemistry 642
- Immunology 279
- Cancer Research 185
Countries citing papers authored by Weier Bao
This map shows the geographic impact of Weier Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weier Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weier Bao more than expected).
Fields of papers citing papers by Weier Bao
This network shows the impact of papers produced by Weier Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weier Bao. The network helps show where Weier Bao may publish in the future.
Co-authors
The 25 scholars most cited alongside Weier Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy Hit paper breakdown → | 2020 | 326 |
| 2 | Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer Hit paper breakdown → | 2019 | 318 |
| 3 | 2019 | 184 | |
| 4 | 2021 | 172 | |
| 5 | 2019 | 170 | |
| 6 | 2018 | 98 | |
| 7 | 2018 | 92 | |
| 8 | 2019 | 91 | |
| 9 | 2021 | 88 | |
| 10 | 2023 | 58 | |
| 11 | 2021 | 55 | |
| 12 | 2023 | 54 | |
| 13 | An oncolytic virus–T cell chimera for cancer immunotherapy Hit paper breakdown → | 2024 | 51 |
| 14 | 2017 | 48 | |
| 15 | 2019 | 42 | |
| 16 | 2019 | 41 | |
| 17 | 2020 | 26 | |
| 18 | 2019 | 23 | |
| 19 | 2021 | 19 | |
| 20 | 2024 | 17 |
About Weier Bao
Weier Bao is a scholar working on Biomedical Engineering, Materials Chemistry, Molecular Biology, Biomaterials and Biochemistry, having authored 35 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (22 papers), Advanced Nanomaterials in Catalysis (8 papers), Advanced biosensing and bioanalysis techniques (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Luminescence and Fluorescent Materials (5 papers), Sulfur Compounds in Biology (4 papers), Extracellular vesicles in disease (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Biomaterials (427 citations), Biomedical Engineering (1.1k citations), Materials Chemistry (642 citations), Immunology (279 citations) and Cancer Research (185 citations). Weier Bao has collaborated with scholars based in China, Netherlands and Saudi Arabia. Frequent co-authors include Wei Wei, Feng Li, Guihong Lu, Yanlin Lv, Shuang Wang, Zhiyuan Tian, Fan Zhang, Bin Liu, Guanghui Ma and Xiaoyong Gao. Their work appears in journals such as Small, ACS Nano, Advanced Materials, Nature Communications and Sensors and Actuators B Chemical.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.